Glucagon-like peptide-1 receptor agonist (GLP-1 RA) exposures reported to U.S. poison centers increased following 2021 U.S. Food and Drug Administration (FDA) approval for weight loss.
Movement breaks are a potentially feasible and effective public health strategy to reduce the harms of prolonged sedentary behavior.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results